2017-02-07 13:02:49 UTC

Tools for Management of C. Diff in IBD

Feb. 9, 2017

AGA Clinical Practice Update, patient guide and community discussion will help you in the treatment of C. diff in IBD.

The latest AGA Clinical Practice Update (CPU) is on the management of Clostridium difficile, or C. diff, infection in inflammatory bowel disease (IBD) patients and provides direction from the AGA CPU Committee for the management of patients with both. You can read the expert review in Clinical Gastroenterology and Hepatology.

  • For you: Andrea Shin, MD, started a discussion and poll in the AGA Community forum to test your knowledge on how to treat C. diff in IBD, using the CPU best-practice advice. Dr. Shin shared the multiple-choice case question in the forum and will provide the correct answer with explanation when the poll closes on Tuesday, Feb. 14.
  • For your patients: In connection with the CPU, AGA created a guide to share with your IBD patients to help them better understand treatment options if they have been diagnosed with C. diff.

Following the poll, the discussion will open as an eQ&A session for your questions and concerns around treating C. diff infection in IBD patients. Take the poll today and then bring your questions to Dr. Shin.

More on Clostridium difficile infection

How to Select the Best FMT Donor

Oct. 25, 2017

Dr. Gail Hecht debunks the myth that a patient’s family or friend is the best donor for a fecal microbiota transplantation.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Study Finds C. Diff Infections on the Rise, FMT Most Promising Treatment

July 5, 2017

AGA is tracking outcomes of fecal microbiota transplantation through an observational registry.